Boule Diagnostics AB (publ) (STO:BOUL)
Sweden · Delayed Price · Currency is SEK 9.92
-0.28 (-2.75%)
Jul 16, 2025, 3:58 PM CET
Boule Diagnostics AB Company Description
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East.
The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand.
It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics companies.
Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.
Boule Diagnostics AB (publ)
| Country | Sweden |
| Founded | 1956 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 200 |
| CEO | Torben Nielsen |
Contact Details
Address: Domnarvsgatan 4 Spånga, 163 53 Sweden | |
| Phone | 46 87 44 77 00 |
| Website | boule.com |
Stock Details
| Ticker Symbol | BOUL |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0011231158 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Torben Nielsen | Chief Executive Officer and Group President |
| Holger Lembrer M.Sc. | Chief Financial Officer |
| Eduardo Pagani | Chief Operating Officer |
| Simonetta Tumbiolo | Senior Vice President of Marketing, Product strategy and Service |
| Eva Sperling | Chief of Staff |